When someone’s body parts are donated, it’s a life-or-death race against the clock as hearts, lungs, livers and hands rapidly deteriorate outside the body.

The partnership will see GamaMabs use MedImmune’s proprietary pyrrolobenzodiazepine (PBD) toxin and linker technology in the research and production of the ADC for targeted cancer therapy. GamaMabs will have exclusive rights to use the proprietary PBD technology in this work and MedImmune will receive an upfront payment, development and commercial milestone payments as well as royalties on net sales.

Immunomic Therapeutics, Inc. (ITI), a privately held, Maryland-based biotechnology company is proud to announce a travel fund for patients enrolled in a Phase II clinical study that employs their investigational LAMP-Vax™ technology to treat glioblastoma multiforme (GBM).

We invite you to participate in the East County Regional Job Fair to be held on Thursday, November 2, 2017 from 3:00 –7:00pm at the East County Community Recreation Center, 3310 Gateshead Manor Way, Silver Spring, MD 20904. We ask that you complete this form by October 25th. We encourage all employers to set-up between 1:00 - 2:30 since the event will start at 3pm prompt!

Lupin said today it has acquired Symbiomix Therapeutics for $150 million cash, in a deal designed to expand the buyer’s branded women’s health specialty drug business.

In acquiring Symbiomix through its U.S. subsidiary, Lupin has exercised an option it retained earlier this year to buy the privately held developer of treatments for gynecologic infections.

For years, proponents of increased downtown development and innovation districts have spoken of the important interplay between universities, startups, and local jobs. Cities such as Pittsburgh, which has seen its stock rise as a center for technology and innovation, found that local universities such as Carnegie Mellon served as catalysts for commercial and creative growth.

Maryland companies raised $181.4 million from venture capitalists in the third quarter, a 435 percent increase from the year before.

There were 13 deals involving Maryland companies in the period, according to the PwC/CB Insights MoneyTree Report released Wednesday. That's two more deals than in the third quarter last year and three fewer than in the second quarter.

Diabetics who have been pricking their fingers for years finally have another option. Freestyle Libre is a small patch that can be easily applied to the upper-arm. With a simple scan, the sensor can read your glucose levels, no needles or blood necessary.

Emergent BioSolutions Inc. EBS announced that it completed the acquisition of FDA-licensed smallpox vaccine's business of Sanofi SNY - ACAM2000.  The company paid an upfront payment of $97.5 million and $20 million in milestone payments. The deal also includes a potential milestone payment of up to $7.5 million, tied to the achievement of remaining regulatory

Emma started work as a massage therapist at NovaHealth TCM Clinic yesterday.

Emma - short for Expert Manipulative Massage Automation - is a robotic massager, developed by a team of researchers, engineers and programmers at AiTreat, a start-up incubated by Nanyang Technological University (NTU). It is particularly good for neck and knee massages.

Academic research is often full of ideas that can form the foundation of startups.

So institutions like the University of Maryland, Baltimore and Johns Hopkins are putting considerable effort to help launch young companies that license that research in a way that can bring acclaim and dollars. But just about everyone still thinks we need more CEOs and scientists working together.

The Northern Virginia health giant's new partnership will give consumers a glimpse into their DNA.

Global demand for fish is growing quickly, but many species are already severely overfished, leaving scientists and industry experts searching for ways to more safely and efficiently farm fish. In response, two UMBC research teams are developing revolutionary innovations for off-shore fish farming, to help mitigate the risks of disease and escapes in captive fish populations. Both recently received extremely competitive awards from the U.S. Department of Agriculture (USDA) to pursue their work further.

The Maryland Stem Cell Research Commission (Commission) approved funding for four awards totaling $1,060,000. With the robust activity in stem cell research in Maryland, the Commission approved the first of two rounds of applications this year for the Validation and Commercialization Programs to accelerate getting solutions to patients.

Osiris Therapeutics, Inc. (Pink Sheets: OSIR), a leading regenerative medicine company focused on developing and marketing products for wound care, orthopedics, and sports medicine, announced today that a new peer reviewed manuscript entitled “Placental Membranes for Management of Refractory Cutaneous Sinus Tracts of Surgical Origin: A Pilot Study” has been published in The Journal of the American College of Clinical Wound Specialists and is available online.

The Richard A. Henson Foundation, Inc. today reaffirmed its commitment to Salisbury University, announcing a $2.5 million gift for SU’s Richard A. Henson School of Science and Technology.

A pioneer in the commuter aviation industry, Henson endowed the school bearing his name with another multi-million-dollar donation in 1987. This latest marks the 30th anniversary of that initial commitment.

The credibility of stem cell research is at risk because of charlatans and dodgy clinics peddling unproven cures for diseases, according to a group of eminent scientists in the field.

Circulomics, a Baltimore, MD-based biotechnology startup, received two SBIR grants totaling over $1.7M.

The company will use the funds to develop new applications of its Nanobind DNA/RNA extraction technology.

[THE INVESTOR] In the age of “digital health care,” high-tech wearables, cutting-edge medical devices and integrated apps combined with major breakthroughs in data computing and analytics capabilities are set to pave new frontiers in the health care sector.

A new academic enterprise, born of a partnership between the University of Washington and China’s Tsinghua University -- and seeded with $40 million in funding from Microsoft -- welcomed its first class of master’s students this fall.

Gene therapy is at the forefront of preventative and therapeutic technologies targeting diseases that have no other cures. Join us as two leading gene therapy experts, Drs. Karen Kozarsky and Lynne Fahey McGrath, discuss different types of gene therapy, advanced programs, and the associated unique regulatory challenges.

Rhythm Pharmaceuticals $RYTM became the latest biotech to tap into a buoyant market, raising $120 million in an IPO that went over the range at $17 a share. And they can add substantially to that if the underwriters pick up another million shares on the table.

We know from following the Rise of the Rest that D.C. isn’t in the top three for metros venture capital investments, but a new study said it makes the top 10.

The Center for Innovative Technology (CIT) announced today the Commonwealth Research Commercialization Fund (CRCF) Request for Proposals (RFP) for FY2018.

TEDCO, the Maryland Technology Development Corporation, awarded four recipients more than $1 million for stem cell research for validation and commercialization of products. LifeSprout and RoosterBio received awards totaling $600,000 to help commercialize products based on stem cell technology.

Johns Hopkins Tech Ventures is expanding its entrepreneurship and incubation services for university students.

What happens to startups when they’ve outgrown coworking, but aren’t ready a whole office suite? There’s an incubator for that.

Accelspace is #dctech’s latest incubator, aimed at high-growth, mid-level, startups. Currently the incubator has offices in downtown D.C. and Crystal City.

The University of Maryland will receive a $219.5 million donation from the A. James and Alice B. Clark Foundation created by the late contracting titan James Clark.

Emergent BioSolutions Inc. (NYSE:EBS) today announced that it has been awarded a contract valued at up to approximately $25 million by the U.S. Department of State to supply TROBIGARD™ (Atropine Sulfate [2mg]/Obidoxime Chloride [220mg]) auto-injector, a drug and device combination product for emergency use in the event of nerve agent or organophosphate poisoning. Trobigard is designed for intramuscular self- or buddy-administration of atropine sulfate and obidoxime chloride for pre-hospital intervention.  

A digital health report from Rock Health showed that women-led companies and geographic diversity continued to build in the third quarter. In the three months through September 30, of the 84 companies that raised $1.2 billion, 16 percent were led by women.

When it comes to high-tech startups, we hear a lot about the so-called “rise of the rest.” As the nation’s leading centers of high-tech industry—places like the San Francisco Bay Area, New York City, Boston, and Seattle—have become increasingly expensive to live in, the argument goes, talented techies, entrepreneurs, and startups are moving to less expensive places like Portland, Pittsburgh, Detroit, Nashville, Las Vegas, and others.

Qiagen has announced that its manufacturing and supply chain for consumables and other products for forensic and human identity testing has been certified by Bureau Veritas, a leading inspection agency, as meeting the latest international standards for products used in forensic testing.

Despite the jurisdictional posturing in Maryland, Virginia and Washington D.C. over a possible Amazon headquarters, a new FBI building or a national football stadium, the recent joint trade mission to Canada by their respective leaders — along with efforts such as the Greater Washington Board of Trade holding its summit at the Pendry Hotel in Baltimore — all augur well for better regional cooperation.

BioMarker Strategies, LLC today announced that the National Cancer Institute (NCI) has awarded the Company a Phase I Small Business Innovation Research (SBIR) grant for development of a pathway-based companion diagnostic test to identify patients with head and neck squamous cell carcinoma (HNSCC) who are most likely to respond to treatment with cetuximab. The grant will provide $299,000 in research support.

WellDoc®, a leading digital health company, announced today the appointment of Laurel Pickering, president and CEO of Northeast Business Group on Health (NEBGH), as the Company’s new Chief Revenue Officer (CRO). Ms. Pickering selected WellDoc as her next opportunity after spending nearly 25 years at the helm of NEBGH, an employer-led coalition of healthcare leaders and other stakeholders. Ms. Pickering will join the WellDoc team in October.